Ethyl 1-methyl-5-nitro-2-imidazolecarboxylate thiosemicarbazone → Megazol

반응식

[CH3:1][N:2]1[C:6]([N+:7]([O-:9])=[O:8])=[CH:5][N:4]=[C:3]1[C:10]([NH:12][NH:13][C:14]([NH2:16])=[S:15])=N.CN1C([N+]([O-])=O)=CN=C1C(=NNC(N)=S)OCC>>[NH2:16][C:14]1[S:15][C:10]([C:3]2[N:2]([CH3:1])[C:6]([N+:7]([O-:9])=[O:8])=[CH:5][N:4]=2)=[N:12][N:13]=1

참가 물질

반응물 2

HCID 54213536Ethyl 1-methyl-5-nitro-2-imidazolecarboxylate thiosemicarbazone

HCID 178481319HCID 178481319, 화합물

생성물 1

HCID 29698Megazol

실험 절차

In a similar manner, acid treatment of the mixture of 1-(1-methyl-5-nitro-2-imidazolecarboximidoyl)-3-thiosemicarbazide and ethyl 1-methyl-5-nitro-2-imidazolecarboxylate thiosemicarbazone, gives the title compound.

출처 및 근거

ORD 기록: ord-0ca7344f40fb4971aadc86fa03ff21f5
출처 데이터셋: uspto-grants-1976_02
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US03940411

반응 노트

불러오는 중…